Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Artemis II shares new lunar images while more than halfway to the moon - 2Which Switch Game Do You Suggest? Share Your Decision
- 3A Concise History Of The Entertainment world
- 4Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
- 5Presenting Nintendo's New Pastel Satisfaction Con Tones for Switch Gamers: 3 Upscale Choices
- Addiction-stricken community struggles to keep a syringe program going after Trump's order
- German economic institutes cut forecast in half over Iran war
- RSF attack on Sudan’s South Kordofan kills at least 14, including children
- Europe picks companies to help build Argonaut moon lander
- Want to read more in 2026? Here's how to revive your love of books
- What will the Artemis 2 astronauts eat during their historic moon mission? (video)
- Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.
- What Middle East Conflict Could Mean For The World’s Largest Whale Shark Gathering
- Palestinians reel under winter rains as Israel blocks Gaza shelter supplies
